RecruitingNCT04529967

Child-Parent Familial Hypercholesterolemia Screening

Child-Parent Screening of Familial Hypercholesterolemia in Children


Sponsor

Children's Hospital of Fudan University

Enrollment

15,000 participants

Start Date

Apr 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Child-parent screening for familial hypercholesterolemia has been proposed to identify children and their parent who are carrier of mutations and with high risk for inherited premature coronary artery disease. The investigators assessed the efficacy and feasibility of such screening in primary care practice. key scientific questions: 1. The 95th and 99th percentile of finger blood TC in children of 2 years old. 2. Mutations that contribute to high TC status ( serum TC \>99th percentiles) compared with international FH48 panel for FH genetic screening.


Eligibility

Min Age: 1 YearMax Age: 3 Years

Inclusion Criteria2

  • Receive routine child care
  • aged 1 - 3 years old ( date of investigate minus date of birth)

Exclusion Criteria1

  • It is up to the researcher to decide whether it is suitable to participate in this research

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERno interventions

it is a observational study, do not have interventions.


Locations(6)

Anhui Provincial Children's Hospital

Hefei, Anhui, China

Qidong Women and Children Hospital

Qidong, Jiangsu, China

Weili Yan

Shanghai, Shanghai Municipality, China

Shanxi Provincial Children's Hospital

Taiyuan, Shanxi, China

Chongqin Medical University Affiliated Children's Hospital

Chongqing, Sichuan, China

Urumqi Children's Hospital

Ürümqi, Xinjiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04529967


Related Trials